Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Filtration00:53

Filtration

Filtration is a physical separation process that involves passing a suspension through a porous medium to separate solids from fluids. During filtration, solids collect on the porous medium while liquids, also collectively known as the filtrate, pass through. The filtration medium is selected based on the filtration purpose, quantity, and nature of the precipitate. The general criteria for a suitable filtering medium are that it is inert, mechanically strong, nonabsorbent toward dissolved...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective cohort study evaluating the predictive value of urinary L-FABP combined with the SOFA score for assessing COVID-19 severity.

PloS oneยท2025
Same author

Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis.

EBioMedicineยท2025
Same author

Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 Patients.

Cureusยท2025
Same author

Detection of <i>Leishmania donovani</i> DNA from Oral Swab in Visceral Leishmaniasis.

Pathogens (Basel, Switzerland)ยท2025
Same author

Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapy.

Scientific reportsยท2024
Same author

Urine oxygenation predicts COVID-19 risk.

Clinical and experimental nephrologyยท2024

Related Experiment Video

Updated: Jul 15, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Double filtration plasmapheresis can decrease factor XIII Activity.

Norio Hanafusa1, Yasushi Kondo, Makoto Suzuki

  • 1Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan. hanafusa-tky@umin.ac.jp

Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
|May 15, 2007
PubMed
Summary

Intense double filtration plasmapheresis (DFPP) significantly reduces Factor XIII (FXIII) activity, potentially impacting wound healing. Monitoring FXIII levels during DFPP is crucial, especially with albumin replacement, to prevent complications.

More Related Videos

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
08:01

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum
09:22

Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum

Published on: April 13, 2018

Related Experiment Videos

Last Updated: Jul 15, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
08:01

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum
09:22

Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum

Published on: April 13, 2018

Area of Science:

  • Hematology
  • Nephrology
  • Critical Care Medicine

Background:

  • Factor XIII (FXIII) is essential for stabilizing fibrin clots and ensuring proper wound healing.
  • Deficiency in FXIII can lead to bleeding disorders and impaired healing.
  • Double filtration plasmapheresis (DFPP) is a procedure used to remove substances from the blood.

Observation:

  • Five patients undergoing intense DFPP showed a significant decrease in FXIII activity, often below 10% of baseline.
  • Standard coagulation tests did not adequately reflect the diminished FXIII levels.
  • FXIII's properties (molecular weight, half-life, distribution volume) make it susceptible to removal by DFPP.

Findings:

  • Intense DFPP therapy is associated with a profound reduction in Factor XIII activity.
  • The decrease in FXIII activity caused by DFPP was clinically observed in the treated patients.
  • Despite low FXIII levels, fatal bleeding was avoided, though one patient required intervention for prolonged bleeding.

Implications:

  • Patients undergoing DFPP, particularly intensified regimens with albumin replacement, require monitoring of FXIII activity.
  • Routine coagulation tests are insufficient to assess FXIII levels during DFPP.
  • Proactive measurement and potential supplementation of FXIII may be necessary to mitigate bleeding risks in patients receiving DFPP.